These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10978947)

  • 1. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
    Veldhuyzen Van Zanten S; Farley A; Marcon N; Lahaie R; Archambault A; Hunt R; Bailey R; Owen D; Spénard J; Stiglick A; Aimola N; Colin P
    Can J Gastroenterol; 2000; 14(7):599-602. PubMed ID: 10978947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.
    Roghani HS; Massarrat S; Pahlewanzadeh MR; Dashti M
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):709-12. PubMed ID: 10445787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
    Lahaie R; Farley A; Dallaire C; Archambault A; Fallone CA; Ponich T; Hunt R; Oravec M; Whitsitt P; Van Zanten SV; Marcon N; Bailey R; Dumont A; Nguyen B; Desrochers S; Spénard J
    Can J Gastroenterol; 2001 Sep; 15(9):581-5. PubMed ID: 11573100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
    BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
    Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
    Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
    Borody TJ; George LL; Brandl S; Andrews P; Lenne J; Moore-Jones D; Devine M; Walton M
    Scand J Gastroenterol; 1992 Apr; 27(4):281-4. PubMed ID: 1589705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
    Sotudehmanesh R; Malekzadeh R; Fazel A; Massarrat S; Ziad-Alizadeh B; Eshraghian MR
    J Gastroenterol Hepatol; 2001 Mar; 16(3):264-8. PubMed ID: 11339416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
    Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
    Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for
    Kim SJ; Chung JW; Woo HS; Kim SY; Kim JH; Kim YJ; Kim KO; Kwon KA; Park DK
    World J Gastroenterol; 2019 Dec; 25(46):6790-6798. PubMed ID: 31857780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.
    De Boer WA; Van Etten RJ; Van De Wouw BA; Schneeberger PM; Van Oijen AH; Jansen JB
    Aliment Pharmacol Ther; 2000 Jan; 14(1):85-9. PubMed ID: 10632650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
    Tursi A; Di Mario F; Franceschi M; De Bastiani R; Elisei W; Baldassarre G; Ferronato A; Grillo S; Landi S; Zamparella M; De Polo M; Boscariolo L; Picchio M
    Helicobacter; 2017 Jun; 22(3):. PubMed ID: 28125857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain.
    Gomollón F; Ducóns JA; Gimeno L; Fuentes J; García S; Vera J; Montoro M
    Helicobacter; 1998 Jun; 3(2):110-4. PubMed ID: 9631309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori: the results of a pilot study of 3, 5 & 7 day triple antibiotic regime with bismuth for one month.
    O'Connor HJ; Cunnane K; Collins JS; Sloan JM; Johnston BT; Bamford KC; Gilvarry J; O'Morain CA
    Ir J Med Sci; 1997; 166(1):32-4. PubMed ID: 9057430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment.
    Songür Y; Senol A; Balkarli A; Baştürk A; Cerçi S
    Am J Med Sci; 2009 Jul; 338(1):50-3. PubMed ID: 19474657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.
    Delchier JC; Malfertheiner P; Thieroff-Ekerdt R
    Aliment Pharmacol Ther; 2014 Jul; 40(2):171-7. PubMed ID: 24863854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
    Salmanroghani H; Mirvakili M; Baghbanian M; Salmanroghani R; Sanati G; Yazdian P
    PLoS One; 2018; 13(6):e0197096. PubMed ID: 29889843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.